Autologous Neo-Bladder Construct in Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence

Withdrawn before enrolling · Phase 2

Conditions studied: Overactive Bladder

In brief

Subjects with non-neurogenic over-active bladder will be enrolled. The hypothesis is that augmentation cystoplasty using an autologous neo-bladder construct will increase functional capacity and thereby reduce the number of micturition episodes per day in subjects with non-neurogenic over active bladder and urge predominant incontinence.

Key facts

Study ID

NCT00594139

Run by

Tengion

People needed

0

Starts

2008-01-01

Expected to finish

2008-01-01

Last updated by the study team

2018-06-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of non-neurogenic overactive bladder for at least 12 months prior to study entry
• Intolerance to medical therapy or persistence of symptoms despite medical therapy

You may not qualify if…

• Subjects with stress incontinence or mixed incontinence where the predominant component is stress incontinence
• Use of Botulinum Toxin A injections into the bladder within the previous 6 months
• Presence of a neuromodulator
• Using catheterization as a way to control incontinence
• History of bladder cancer

Where it is running

• Vanderbilt University — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.